Polar Capital Holdings’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Polar Capital Holdings’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,568,385	Closed	-$44.9M	–	371
2020 Q4	$44.9M	Buy	+2,568,385	New	+$36M	0.27%	104

Polar Capital Holdings's OXFD Position: Q1 2021 in Review

Polar Capital Holdings sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 2,568,385 shares — an estimated $44.9M sold.

Polar Capital Holdings first reported a position in OXFD in Q4 2020 and held it in 1 quarter. The position peaked at $44.9M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

Polar Capital Holdings reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
Polar Capital Holdings sold 2,568,385 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $44.9M.
Polar Capital Holdings first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2020 and held it in 1 quarter.
Polar Capital Holdings's Oxford Immunotec Global PLC Ordinary Shares position peaked at $44.9M in Q4 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Polar Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.